Evidence map›Paper›PMID 33567497›Full record

ArticleDiagnostics (Basel, Switzerland)2021

Autofluorescence Imaging of the Skin Is an Objective Non-Invasive Technique for Diagnosing Pseudoxanthoma Elasticum.

Klára Farkas, Szabolcs Bozsányi, Dóra Plázár, András Bánvölgyi, Luca Fésűs, Pálma Anker, Sára Zakariás, Ilze Lihacova, Alexey Lihachev, Marta Lange and 4 more

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. [Dermoscopy of genodermatoses].Dermatologie (Heidelberg, Germany) · 2023
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Klára FarkasDepartment of Dermatology, Venereology and Dermatooncology, Semmelweis University, 1085 Budapest, Hungary.ORCID 0000-0002-8185-1346
Szabolcs BozsányiDepartment of Dermatology, Venereology and Dermatooncology, Semmelweis University, 1085 Budapest, Hungary.ORCID 0000-0002-1391-419X
Dóra PlázárDepartment of Dermatology, Venereology and Dermatooncology, Semmelweis University, 1085 Budapest, Hungary.
András BánvölgyiDepartment of Dermatology, Venereology and Dermatooncology, Semmelweis University, 1085 Budapest, Hungary.
Luca FésűsDepartment of Dermatology, Venereology and Dermatooncology, Semmelweis University, 1085 Budapest, Hungary.
Pálma AnkerDepartment of Dermatology, Venereology and Dermatooncology, Semmelweis University, 1085 Budapest, Hungary.ORCID 0000-0003-4690-7743
Sára ZakariásDepartment of Dermatology, Venereology and Dermatooncology, Semmelweis University, 1085 Budapest, Hungary.
Ilze LihacovaBiophotonics Laboratory, Institute of Atomic Physics and Spectroscopy, University of Latvia, LV-1004 Riga, Latvia.ORCID 0000-0002-8102-7373
Alexey LihachevBiophotonics Laboratory, Institute of Atomic Physics and Spectroscopy, University of Latvia, LV-1004 Riga, Latvia.ORCID 0000-0003-4178-895X
Marta LangeBiophotonics Laboratory, Institute of Atomic Physics and Spectroscopy, University of Latvia, LV-1004 Riga, Latvia.
Tamás ArányiDepartment of Molecular Biology, Semmelweis University, 1085 Budapest, Hungary.
Norbert M WikonkálDepartment of Dermatology, Venereology and Dermatooncology, Semmelweis University, 1085 Budapest, Hungary.
Márta MedveczDepartment of Dermatology, Venereology and Dermatooncology, Semmelweis University, 1085 Budapest, Hungary.ORCID 0000-0002-3126-096X
Norbert KissDepartment of Dermatology, Venereology and Dermatooncology, Semmelweis University, 1085 Budapest, Hungary.ORCID 0000-0002-9947-1755
Semmelweis University · HUUniversity of Latvia · LV

Funding

EFOP- 3.6.3-VEKOP 16-2017-00009European Regional Development Fund projects "Development and clinical validation of a novel cost effective multi-modal methodology for early diagnostics of skin cancers" No. 1.1.1.2/16/I/001 agreement No. 1.1.1.2/VIAA/1/16/052European Regional Development Fund projects "Time-resolved autofluorescence methodology for non-invasive skin cancer diagnostics" No. 1.1.1.2/16/I/001, agreement No. 1.1.1.2/VIAA/1/16/014EuroSoftCalcNet COST action CA16115National Research, Development and Innovation Office FK_131916, 2019National Research, Development and Innovation Office K_132695, 2019New National Excellence Program of the Ministry For Innovation and Technology from the source of the National Research, Development and Innovation Fund of Hungary ÚNKP-20-3-I-SE-24New National Excellence Program of the Ministry For Innovation and Technology from the source of the National Research, Development and Innovation Fund of Hungary ÚNKP-20-4-II-SE-7
6 · The paper itself

Abstract

Pseudoxanthoma elasticum (PXE) is a rare multisystemic autosomal recessive connective tissue disease. In most cases, skin manifestations of PXE are the first to develop, followed later by severe ocular and cardiovascular complications. In our present study, in addition to dermoscopy, we introduced novel techniques, autofluorescence (AF) and diffuse reflectance (DR) imaging for the assessment of affected skin sites of five PXE patients. PXE-affected skin areas in most skin sites showed a previously observed pattern upon dermoscopic examination. With the novel imaging, PXE-affected skin lesions displayed high AF intensity. During our measurements, significantly higher mean, minimum and maximum AF intensity values were found in areas of PXE-affected skin when compared to uninvolved skin. Conversely, images acquired with the use of 660 and 940 nm illumination showed no mentionable difference. Our results demonstrate that AF imaging may be used in the in vivo diagnostics and quantification of the severity of the skin lesions of PXE patients. In addition, it is a safe, fast and cost-effective diagnostic method. AF imaging may be also used to objectively monitor the efficacy of the possible novel therapeutic approaches of PXE in the future.

Indexed as

autofluorescence imagingcalcificationdermoscopydiagnosisdiffuse reflectance imagingLEDpseudoxanthoma elasticumquantitative analysis

Identifiers

PMID33567497
PMCPMC7915757
OpenAlexW3129167422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.